SLC3A2 and mature T-cell and NK-cell non-Hodgkin lymphoma: Collectively, these results suggest that arginine uptake is overly active in PTCL tumor cells and that SLC3A2, a putative arginine transporter, is highly expressed in patients with PTCL and predicts poor prognosis.